檢索結果 - Richel, D J
- Showing 1 - 10 results of 10
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Could recombinant insulin compounds contribute to adenocarcinoma progression by stimulating local angiogenesis? 由 Rensing, K. L., Houttuijn Bloemendaal, F. M., Weijers, E. M., Richel, D. J., Büller, H. R., Koolwijk, P., van der Loos, C. M., Twickler, Th. B., von der Thüsen, J. H.
出版 2010Text -
8
High-dose carboplatin, thiotepa and cyclophosphamide (CTC) with peripheral blood stem cell support in the adjuvant therapy of high-risk breast cancer: a practical approach. 由 van der Wall, E., Nooijen, W. J., Baars, J. W., Holtkamp, M. J., Schorangel, J. H., Richel, D. J., Rutgers, E. J., Slaper-Cortenbach, I. C., van der Schoot, C. E., Rodenhuis, S.
出版 1995Text -
9
A randomised phase II multicentre trial of irinotecan (CPT-11) using four different schedules in patients with metastatic colorectal cancer 由 Schoemaker, N E, Kuppens, I E L M, Moiseyenko, V, Glimelius, B, Kjaer, M, Starkhammer, H, Richel, D J, Smaaland, R, Bertelsen, K, Poulsen, J P, Voznyi, E, Norum, J, Fennelly, D, Tveit, K M, Garin, A, Gruia, G, Mourier, A, Sibaud, D, Lefebvre, P, Beijnen, J H, Schellens, J H M, ten Bokkel Huinink, W W
出版 2004Text -
10
Population PKPD of paclitaxel and carboplatin in ovarian cancer patients: A study by the EORTC-PAMM-NDDG 由 Joerger, M, Huitema, A D R, Richel, D J, Dittrich, C, Pavlidis, N, Briasoulis, E, Vermorken, J B, Strocchi, E, Martoni, A, Sorio, R, Sleeboom, H P, Izquierdo, M A, Jodrell, D I, Calvert, A H, Boddy, A, Hollema, H, Féty, R, Van der Vijgh, W J F, Hempel, G, Chatelut, E, Karlsson, M, Tranchand, B, Schrijvers, A H G J, Beijnen, J H, Schellens, J H M
出版 2007Text